Europe Breast Reconstruction Market

Market Introduction

Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.

Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.

The impact of the COVID-19 pandemic on cancer patients is high in terms of anxiety, fear, and psychological distress. In Among all European countries, Spain, Italy, Germany, France, and UK are most affected due to increasing number of coronavirus cases and deaths associated with it. As per the news article, in Italy, due to Covid-19 emergency, access for thousands of cancer patients in need of chemotherapy, scans, transplants and surgery has become difficult. According to the research led by Codice Viola, charity that supports pancreatic cancer patients found that more than 500 breast or pancreatic patients’ appointments for chemotherapy or radiotherapy were postponed. Additionally, 64% of surgical procedures were postponed and more than half have had follow-up appointments rescheduled. The Covid-19 pandemic has challenged hard the national health systems worldwide. According to the national policy issued in March 2020 in response to the evolving Covid-19 pandemic, several hospitals were re-configured as Covid-19 centers and elective surgery procedures were rescheduled according to the most recent recommendations. In addition, Covid-19 protected cancer hubs were established, including the Regina Elena National Cancer Institute of Rome, Central Italy.

Market Overview and Dynamics

The Breast reconstruction market in Europe is expected to grow from US$ 135.8 million in 2021 to US$ 197.2 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028. The surgeons performing implant-breast reconstruction procedures face various challenges in terms of providing sufficient soft tissue coverage and support to implant, defining a natural breast shape, avoiding problems related to contracture, and so on, which act as hindrance in achieving optimum results. However, the adoption of ADM in the recent years has helped them overcome the aforementioned issues. ADM is a soft tissue substitute derived from donated human skin tissue. The tissue undergoes a multi-step proprietary process to avoid chances of rejection, which mainly involves removing cells that can cause antigenic response in the receiver’s body. The use of ADM also helps skip skin grafting procedure and harvesting tissues from one’s own body, which acts as an advantage for the patients as well as healthcare providers. Moreover, these matrices are available in different shapes, sizes, and thicknesses to meet the specific needs of the patients.

Key Market Segments

In terms of technology, the inframammary segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the Europe breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc, Mentor Worldwide LLC (Subsidiary of Johnson & Johnson), GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, HANSBIOMED CO. LTD, Establishment Labs S.A., and Groupe Sebbin SAS.

Reasons to buy report

• To understand the Europe breast reconstruction market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe breast reconstruction market
• Efficiently plan M&A and partnership deals in Europe Breast reconstruction market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Breast reconstruction market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

EUROPE BREAST RECONSTRUCTION MARKET SEGMENTATION

By Technology

• Inframammary
• Peri-Areolar
• Trans-Axillary
• Transumbilical

By Type

• Breast Implants
• Implant’s accessories

By Placement

• Dual Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

By Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

By Country

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Companies Mentioned

1. Allergan Plc
2. Mentor Worldwide LLC (Subsidiary of Johnson & Johnson)
3. GC Aesthetics PLC
4. POLYTECH Health & Aesthetics GmbH
5. HANSBIOMED CO. LTD
6. Establishment Labs S.A.
7. Groupe Sebbin SAS

Europe Breast Reconstruction Market Strategic Insights

Europe Breast Reconstruction Market Segmentation Analysis

Europe Breast Reconstruction Market Report Highlights

Europe Breast Reconstruction Report Scope

Europe Breast Reconstruction Market Country and Regional Insights